Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

81.22
Delayed Data
As of Sep 28
 +0.34 / +0.42%
Today’s Change
69.90
Today|||52-Week Range
95.11
-5.60%
Year-to-Date
10 Stocks John Rogers Keeps Buying
Sep 27 / GuruFocus News - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Kite Pharma Reports Favorable Data from Lymphoma Study
Sep 27 / Zacks.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Why Kite Pharma's Stock Is Soaring Today
Sep 27 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
Sep 26 / TheStreet.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
Is This New Market the Biggest Investment Idea of the Decade?
Sep 17 / MotleyFool.com - Paid Partner Content
Novartis Ilaris Approved for Extended Use in Periodic Fever
Sep 26 / Zacks.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content